Delivery Order SPE2DB20D2104-SPE2DB25FMFJK

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,559.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of December 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $45,782.27, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to...
This federal contract award, valued at $11,569.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $65,899.75, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $15,749.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of JARDIANCE 25 MG TABLET 90S, a medication used in the treatment of conditions related to cardiovascular health and diabetes management. The contract has an ultimate completion date of December 16, 2024 and is a firm fixed-price agreement....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,475.98, is for the delivery of 4564119307 JARDIANCE 25 MG TABLET 90S and has an ultimate completion date of April 1, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $3,786.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product JARDIANCE 10 MG TABLET 90S, with a completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The Firm Fixed Price contract, valued at $18,158.71, has an ultimate completion date of November 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,328.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is a delivery order with a firm fixed price of $47,816.59 and a completion date of February 21, 2024. The contract is for the provision of JARDIANCE 25 MG TABLET 90S, a prescription medication. This award is not associated with any set-aside designation. It falls under a larger indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFJK
    Delivery Order

This federal contract award, valued at $17,209.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication, with a completion date of January 6, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 10:43 AM